IAM Advisory, LLC

Position in ABBV — AbbVie Inc.

CIK 1825292 EASTON, PA

Position in ABBV

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$350,786

+$60,220 QoQ

Shares Held

1,394

+4.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#3,481

of 4,153 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

IAM Advisory, LLC holds $17,989,599 across 8 Drug Manufacturers - General names. ABBV ranks #8 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	4,638	$5,562,956
2	MRK	Merck & Co., Inc.	23,515	$3,021,677
3	AMGN	Amgen Inc	7,484	$2,710,106
4	NVS	Novartis AG	16,635	$2,607,037
5	BMY	Bristol Myers Squibb Co	33,075	$1,905,781
6	GILD	Gilead Sciences, Inc.	11,409	$1,441,413
7	JNJ	Johnson & Johnson	1,535	$389,843
8	ABBV	AbbVie Inc. This page	1,394	$350,786

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$350,786	1,394	+4.3%	Shares	Sole	2026-07-14
2026-03-31	$290,566	1,336	-1.2%	Shares	Sole	2026-04-10
2025-12-31	$308,918	1,352	-8.6%	Shares	Sole	2026-01-07
2025-09-30	$342,447	1,479	+0.8%	Shares	Sole	2025-10-20
2025-06-30	$272,304	1,467	+9.9%	Shares	Sole	2025-07-08
2025-03-31	$279,709	1,335	-12.3%	Shares	Sole	2025-04-11
2024-12-31	$270,459	1,522	-0.1%	Shares	Sole	2025-01-15
2024-09-30	$300,762	1,523	+0.8%	Shares	Sole	2024-10-07
2024-06-30	$259,166	1,511	-1.0%	Shares	Sole	2024-07-12
2024-03-31	$277,884	1,526	+2.6%	Shares	Sole	2024-04-15
2023-12-31	$230,595	1,488	+0.2%	Shares	Sole	2024-01-12
2023-09-30	$221,354	1,485	—	Shares	Sole	2023-10-10
No filing history on record for this holder in this stock.